Our Unique Approach Includes:
Novel PARPi Platform
Predictive Companion Diagnostic
Targeted Alpha Therapy
Our team has extensive experience in small molecule radiopharmaceuticals and a proven track record in scientific research and multi-center trials. Our prestigious board of scientific advisors provides guidance, expertise and oversight to ensure that we are well-positioned for rapid commercialization of our unique theragnostic solution.